Skip to main content

Cerebral Palsy

22
Pipeline Programs
30
Companies
50
Clinical Trials
7 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
13
0
4
0
3
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

31 companies ranked by most advanced pipeline stage

Angeles Therapeutics
1
2
Ropivacaine injectionPhase 41 trial
Ropivacaine injectionPhase 41 trial
High frequency, low magnitude vibrationPhase 21 trial
Augment Reality ExergamesN/A1 trial
Cionic Neural Sleeve NS-100N/A1 trial
+1 more programs
Active Trials
NCT06096272Recruiting30Est. Sep 2025
NCT05660096Withdrawn0Est. Dec 2026
NCT04561232Completed60Est. Aug 2025
+3 more trials
Human BioSciences
Human BioSciencesWV - Martinsburg
29 programs
5
2
1
magnesium sulfatePhase 31 trial
Botulinum toxin type APhase 21 trial
Pediatric Constraint-Induced Movement therapyPhase 21 trial
Robotic Ankle Assist DevicePhase 11 trial
Sprint-Intensity Interval Training with TelecoachingPhase 11 trial
+24 more programs
Active Trials
NCT04997109Recruiting267Est. Feb 2027
NCT03635775Completed20Est. Feb 2020
NCT01217242Completed128Est. Dec 2011
+25 more trials
Medtronic
MedtronicNJ - Phillipsburg
2 programs
1
baclofen, intrathecalPhase 31 trial
Intrathecal Baclofen PumpN/A1 trial
Active Trials
NCT05817409Not Yet Recruiting75Est. Dec 2027
NCT00367068Completed18Est. May 2007
Shionogi
ShionogiJapan - Osaka
1 program
1
Oral Glycopyrrolate LiquidPhase 31 trial
Active Trials
NCT00491894Completed137Est. Jun 2008
SpineX
SpineXCA - Northridge
2 programs
1
1
SCiPPhase 21 trial
SCiPPhase 11 trial
Active Trials
NCT04882592Unknown50Est. Dec 2024
NCT05720208Unknown60Est. Sep 2025
Alliance Pharmaceuticals
2 programs
1
Matched sibling donor cord blood cell infusionPhase 11 trial
Natural History of Cerebral Palsy Prospective StudyN/A1 trial
Active Trials
NCT05576948Recruiting100Est. Sep 2027
NCT03087110Completed12Est. Dec 2020
Spine BioPharma
Spine BioPharmaNY - New York
2 programs
2
Autologous bone marrow mononuclear cell transplantationPhase 11 trial
Intrathecal autologous bone marrow mononuclear cell transplantationPhase 11 trial
Active Trials
NCT01978821Withdrawn0Est. Aug 2013
NCT02241395Withdrawn0Est. Dec 2018
Biocorp
BiocorpFrance - Issoire
1 program
1
ASTROSTEMPhase 11 trial
Active Trials
NCT03979898Completed1Est. May 2019
R-Bio
R-BioTX - Houston
1 program
1
ASTROSTEMPhase 1
Biomotum
BiomotumOR - Portland
1 program
1
Robotic Ankle Assist DevicePhase 1
StemCyte
StemCyteCA - Baldwin Park
1 program
1
hUCBPhase 11 trial
Active Trials
NCT06377982Not Yet Recruiting12Est. Dec 2028
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
5 programs
Cerebral Palsy Adult Transition Longitudinal StudyN/A1 trial
Long-Term Outcomes of Hip Interventions for Children With Cerebral PalsyN/A1 trial
Outcomes of the Evans Calcaneal Lengthening Based on Bone Grafting MaterialN/A1 trial
The intervention group: Neurophysiologically Based Occupational Therapy InterventionN/A1 trial
oral analgesicN/A1 trial
Active Trials
NCT02137005Active Not Recruiting72Est. Dec 2026
NCT04792606Recruiting1,000Est. Mar 2028
NCT02075853Completed20Est. Nov 2018
+2 more trials
Ipsen
IpsenChina - Tianjin
3 programs
Botulinum toxin type APHASE_21 trial
Botulinum toxin type APHASE_31 trial
Botulinum toxin type APHASE_31 trial
Active Trials
NCT00455637Terminated6Est. Mar 2008
NCT01251380Completed216Est. Jan 2015
NCT01249417Completed241Est. Jun 2014
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
2 programs
Balance and Posture in Adults With Cerebral PalsyN/A1 trial
Sensory Integration TestingN/A1 trial
Active Trials
NCT01585571Completed80Est. Feb 2020
NCT02456376Unknown20Est. Dec 2016
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
2 programs
Permobil Explorer MiniN/A
Targeted TrainingN/A1 trial
Active Trials
NCT02097836Completed11Est. Jan 2010
Nielsen BioSciences
Nielsen BioSciencesCA - San Diego
1 program
Cerebral Palsy & Predictors of Physical ActivityN/A1 trial
Active Trials
NCT04614207Completed123Est. Jan 2022
Ability Pharma
Ability PharmaSpain - Cerdanyola
1 program
Empowering youth towards employmentN/A1 trial
Active Trials
NCT02522507Completed44Est. Jul 2020
Ottobock
OttobockNEW YORK, NY
1 program
Exopulse Mollii SuitN/A1 trial
Active Trials
NCT05885139Unknown34Est. Jun 2024
Martin Pharmaceuticals
1 program
High Intensity Interval TrainingN/A1 trial
Active Trials
NCT02319122Completed22Est. Jul 2017
Hamilton medical
Hamilton medicalSwitzerland - Bonaduz
1 program
Implementation groupN/A1 trial
Active Trials
NCT06537622Not Yet Recruiting2,000Est. Nov 2028
Alder Therapeutics
Alder TherapeuticsSweden - Solna
1 program
Long-Term Outcomes of Hip Interventions for Children With Cerebral PalsyN/A
Cosmo Pharmaceuticals
Cosmo PharmaceuticalsIreland - Dublin
1 program
Powered Exoskeleton Gait TrainingN/A1 trial
Active Trials
NCT05759182Completed10Est. Nov 2024
Walden Biosciences
Walden BiosciencesMA - Cambridge
1 program
The intervention group: Neurophysiologically Based Occupational Therapy InterventionN/A
Chong Kun Dang Pharmaceutical
1 program
Umbilical Cord Blood therapyN/A1 trial
Active Trials
NCT01991145Completed92Est. Jun 2017
Illumina
IlluminaCA - Hayward
1 program
Whole-genome sequencingN/A1 trial
Active Trials
NCT05858268Active Not Recruiting66Est. Jan 2026
Sound Pharmaceuticals
1 program
home-based treadmill trainingN/A1 trial
Active Trials
NCT02424526Completed19Est. Sep 2018
Libra Therapeutics
Libra TherapeuticsCA - San Diego
1 program
reproducibility of upper extremity strength measurementsN/A1 trial
Active Trials
NCT02146989Completed370Est. Mar 2018
Verona Pharma
Verona PharmaUK - London
1 program
Device: Electromechanical gait trainerPHASE_11 trial
Active Trials
NCT01564433Completed20Est. Jan 2012
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
umbilical cord bloodPHASE_2
Connect Biopharma
Connect BiopharmaSAN DIEGO, CA
1 program
umbilical cord bloodPHASE_21 trial
Active Trials
NCT01988584Completed20Est. Feb 2018

+1 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Angeles TherapeuticsRopivacaine injection
Angeles TherapeuticsRopivacaine injection
Jazz PharmaceuticalsSativex
IpsenBotulinum toxin type A
IpsenBotulinum toxin type A
ShionogiOral Glycopyrrolate Liquid
Medtronicbaclofen, intrathecal
Human BioSciencesmagnesium sulfate
SpineXSCiP
Connect Biopharmaumbilical cord blood
IpsenBotulinum toxin type A
Angeles TherapeuticsHigh frequency, low magnitude vibration
Human BioSciencesPediatric Constraint-Induced Movement therapy
Human BioSciencesBotulinum toxin type A
StemCytehUCB

Showing 15 of 50 trials with date data

Clinical Trials (50)

Total enrollment: 7,979 patients across 50 trials

NCT06189781Angeles TherapeuticsRopivacaine injection

Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

Start: Dec 2023Est. completion: Jun 202790 patients
Phase 4Recruiting
NCT04074265Angeles TherapeuticsRopivacaine injection

Peri-operative Use of a Pain Injection in Pediatric Patients With Cerebral Palsy

Start: Dec 2019Est. completion: Apr 202334 patients
Phase 4Completed

A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years

Start: Dec 2013Est. completion: Mar 201772 patients
Phase 3Completed
NCT01251380IpsenBotulinum toxin type A

Dysport® Pediatric Lower Limb Spasticity Follow-on Study

Start: Oct 2011Est. completion: Jan 2015216 patients
Phase 3Completed
NCT01249417IpsenBotulinum toxin type A

Dysport® Pediatric Lower Limb Spasticity Study

Start: Jul 2011Est. completion: Jun 2014241 patients
Phase 3Completed
NCT00491894ShionogiOral Glycopyrrolate Liquid

Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions

Start: Mar 2007Est. completion: Jun 2008137 patients
Phase 3Completed
NCT00367068Medtronicbaclofen, intrathecal

Dutch National ITB Study in Children With Cerebral Palsy

Start: Jan 2002Est. completion: May 200718 patients
Phase 3Completed

Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)

Start: Dec 1997Est. completion: Jun 20072,136 patients
Phase 3Completed

Spinal Cord Innovation in Pediatrics (SCiP) to Treat SensoriMotor Function in Children Cerebral Palsy: Protocol for a Randomized Controlled Trial

Start: Sep 2023Est. completion: Sep 202560 patients
Phase 2Unknown
NCT01988584Connect Biopharmaumbilical cord blood

Safety and Effectiveness of Banked Cord Blood or Bone Marrow Stem Cells in Children With Cerebral Palsy (CP).

Start: Nov 2013Est. completion: Feb 201820 patients
Phase 2Completed
NCT00455637IpsenBotulinum toxin type A

Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?

Start: Mar 2007Est. completion: Mar 20086 patients
Phase 2Terminated
NCT00295295Angeles TherapeuticsHigh frequency, low magnitude vibration

Vibration Intervention to Improve Bone and Muscle in Children With Cerebral Palsy

Start: Sep 2004Est. completion: Sep 200734 patients
Phase 2Completed
NCT00061139Human BioSciencesPediatric Constraint-Induced Movement therapy

Constraint-Based Therapy to Improve Motor Function in Children With Cerebral Palsy

Start: Sep 2002Est. completion: Sep 200652 patients
Phase 2Unknown
NCT00060957Human BioSciencesBotulinum toxin type A

Botulinum Toxin (BOTOX) for Cerebral Palsy

Start: Jul 199740 patients
Phase 2Completed

Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy

Start: Sep 2025Est. completion: Dec 202812 patients
Phase 1Not Yet Recruiting
NCT06455930Human BioSciencesStand-on ride-on power mobility device

Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy

Start: Jun 2024Est. completion: Jul 202610 patients
Phase 1Recruiting
NCT05619211Human BioSciencesSprint-Intensity Interval Training with Telecoaching

Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities

Start: Sep 2023Est. completion: Dec 202542 patients
Phase 1Completed
NCT05336227Human BioSciencesVirtual Reality Exergaming

Telehealth Virtual Reality Gaming on Cardiometabolic Health Among Youth With Cerebral Palsy

Start: Jun 2022Est. completion: Feb 202532 patients
Phase 1Completed

Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy

Start: May 2021Est. completion: Dec 202450 patients
Phase 1Unknown
NCT04516343Human BioSciencesRobotic Ankle Assist Device

Development of a Robotic Ankle Assist Device

Start: Nov 2020Est. completion: Aug 202431 patients
Phase 1Completed

Evaluating Wearable Robotic Assistance on Gait

Start: Sep 2019Est. completion: Nov 20226 patients
Phase 1Completed

Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP

Start: Jun 2017Est. completion: May 20191 patients
Phase 1Completed
NCT03087110Alliance PharmaceuticalsMatched sibling donor cord blood cell infusion

Stem Cells in Umbilical Blood Infusion for CP

Start: Mar 2016Est. completion: Dec 202012 patients
Phase 1Completed
NCT02241395Spine BioPharmaIntrathecal autologous bone marrow mononuclear cell transplantation

Cell Therapy as Treatment for Cerebral Palsy

Start: Aug 2013Est. completion: Dec 20180
Phase 1Withdrawn
NCT01564433Verona PharmaDevice: Electromechanical gait trainer

Effects of Electromechanical Gait Trainer in Patients With Cerebral Palsy

Start: Nov 2011Est. completion: Jan 201220 patients
Phase 1Completed
NCT01978821Spine BioPharmaAutologous bone marrow mononuclear cell transplantation

Stem Cell Therapy for Cerebral Palsy

Start: Aug 2010Est. completion: Aug 20130
Phase 1Withdrawn
NCT06537622Hamilton medicalImplementation group

Best Practices Fo Early Diagnosis of Cerebral Palsy

Start: Feb 2025Est. completion: Nov 20282,000 patients
N/ANot Yet Recruiting
NCT05759182Cosmo PharmaceuticalsPowered Exoskeleton Gait Training

The Effects of Exoskeletal Robot-Assisted Gait Training on Children With Cerebral Palsy: A Pilot Study

Start: Sep 2024Est. completion: Nov 202410 patients
N/ACompleted
NCT06096272Angeles TherapeuticsAugment Reality Exergames

Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy

Start: Jun 2024Est. completion: Sep 202530 patients
N/ARecruiting
NCT05660096Angeles TherapeuticsCionic Neural Sleeve NS-100

Pediatric Neural Sleeve Validation

Start: Jan 2024Est. completion: Dec 20260
N/AWithdrawn
NCT04303078Human BioSciencesVarying levels of harness support during walking

Quantifying Energetic Demands of Walking for People With Cerebral Palsy

Start: Aug 2023Est. completion: Jun 202534 patients
N/ACompleted
NCT05817409MedtronicIntrathecal Baclofen Pump

Predictive Factors for Succes of ITB in CP

Start: Jun 2023Est. completion: Dec 202775 patients
N/ANot Yet Recruiting
NCT05885139OttobockExopulse Mollii Suit

Exopulse Mollii Suit, Motor Functions & CP Children With Cerebral Palsy

Start: Apr 2023Est. completion: Jun 202434 patients
N/AUnknown
NCT05858268IlluminaWhole-genome sequencing

NeuralNET Cerebral Palsy Pilot Study

Start: Apr 2023Est. completion: Jan 202666 patients
N/AActive Not Recruiting
NCT05764681Human BioSciencesChronic Postsurgical Pain

Chronic Postsurgical Pain

Start: Mar 2023Est. completion: Jan 2029500 patients
N/ARecruiting
NCT05576948Alliance PharmaceuticalsNatural History of Cerebral Palsy Prospective Study

Natural History of Cerebral Palsy Prospective Study

Start: Sep 2022Est. completion: Sep 2027100 patients
N/ARecruiting

Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

Start: Feb 2022Est. completion: Feb 2027267 patients
N/ARecruiting
NCT05130528Human BioSciencesSensorimotor Intervention

Therapeutic Intervention Supporting Development From NICU to 6 Months for Infants Post Hypoxic-Ischemic Encephalopathy

Start: Feb 2022Est. completion: Apr 202412 patients
N/ACompleted
NCT04612049Human BioSciencesImmersive virtual reality visuo-motor skill assessment

Immersive Virtual Reality for Visuo-motor Integration Skill Assessment

Start: May 2021Est. completion: Dec 202112 patients
N/ATerminated
NCT04684576Human BioSciencesPermobil Explorer Mini

Early Powered Mobility for Toddlers With Cerebral Palsy Using the Permobil® Explorer Mini and a Modified Ride-On Car

Start: Apr 2021Est. completion: May 202224 patients
N/ACompleted
NCT04561232Angeles TherapeuticsProne and Upright Locomotor Training

Locomotor Learning in Infants at High Risk for Cerebral Palsy

Start: Dec 2020Est. completion: Aug 202560 patients
N/ACompleted
NCT05465239Human BioSciencesSurePace Powered Walker User

Intelligent and Adaptive Control Applied to Powered Walkers

Start: Dec 2020Est. completion: Sep 202348 patients
N/ACompleted
NCT04614207Nielsen BioSciencesCerebral Palsy & Predictors of Physical Activity

Cerebral Palsy & Predictors of Physical Activity

Start: Nov 2020Est. completion: Jan 2022123 patients
N/ACompleted
NCT04792606Colorado TherapeuticsLong-Term Outcomes of Hip Interventions for Children With Cerebral Palsy

Long-Term Outcomes of Hip Interventions for Children With Cerebral Palsy

Start: Oct 2019Est. completion: Mar 20281,000 patients
N/ARecruiting

NEO Rehab Program for Premature Infants at Risk for Cerebral Palsy

Start: May 2019Est. completion: Aug 202170 patients
N/ACompleted
NCT03625570Human BioSciencesPower training combined with interval treadmill training

Power Training Combined With Interval Treadmill Training

Start: Apr 2019Est. completion: Nov 202344 patients
N/ACompleted

Single-session tDCS in Cerebral Palsy

Start: May 2018Est. completion: Feb 202020 patients
N/ACompleted
NCT02925455Human BioSciencesContralaterally-controlled functional electrical stimulation

Contralaterally Controlled FES for Hand Opening in Hemiplegic Cerebral Palsy

Start: Oct 2016Est. completion: Apr 202015 patients
N/ACompleted
NCT02522507Ability PharmaEmpowering youth towards employment

A Peer E-mentoring Intervention to Improve Employment

Start: Jan 2016Est. completion: Jul 202044 patients
N/ACompleted
NCT02424526Sound Pharmaceuticalshome-based treadmill training

Intensive Home-based Treadmill Training and Walking Attainment in Young Children With Cerebral Palsy

Start: Jul 2015Est. completion: Sep 201819 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 late-stage (Phase 3) programs, potential near-term approvals
7 actively recruiting trials targeting 7,979 patients
30 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.